White Claw helped make hard seltzer a staple for American drinkers. Now it's getting into the spirit business with its own vodka brand because of new rules passed during the pandemic.

The company's new vodka line was made possible by a change in regulations by the Alcohol and Tobacco Tax and Trade Board (TTB). Previously, the agency required spirits to be "without distinctive character, aroma, taste, or color," but that rule was lifted in 2020.

"We believe that quality vodka shouldn't be defined by what it lacks, and we seized the enormous opportunity to create a distinctive spirit," said Anthony von Mandl, O.C., O.B.C., founder & CEO of The Mark Anthony Group of Companies, which owns White Claw.

"We disrupted the industry, creating an entirely new taste in the Hard Seltzer category with White Claw by bringing new thinking, technology breakthroughs, and our unmatched iconic flavors to market."

The company said it uses a high-pressure filtration process that gives the vodka a smooth, aromatic taste.

"We spent almost a decade researching and developing a new way to show drinkers what complexity looks, tastes, and feels like within the minimalist experience of vodka," von Mandl said.

White Claw's venture into spirits comes amid an industry-wide push to innovate alcoholic beverages, with many companies embracing "ready-to-drink," low-calorie, and healthier options.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More